Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Poynard

Showing results (201-210 of 222) with videos related to

Pageof 23
Sort By:
Diabetes Care|April 12, 2023
High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low ThresholdLaurent Castera, Cédric Laouenan, Anaïs Vallet-Pichard, et al.
Journal of Clinical Medicine|December 8, 2019
Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV InfectionChristiana Graf, Antonia Mondorf, Viola Knop, et al.
Gastroenterology|May 26, 2012
Factors that predict response of patients with hepatitis C virus infection to boceprevirFred Poordad, Jean-Pierre Bronowicki, Stuart C Gordon, et al.
Journal of Hepatology|June 11, 2023
Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosisLaure Elkrief, Nathalie Ganne-Carrié, Hana Manceau, et al.
Plos One|December 30, 2017
Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recoveryValentina Peta, Chantal Tse, Hugo Perazzo, et al.
Nature Medicine|January 31, 2006
A novel dendritic cell subset involved in tumor immunosurveillanceJulien Taieb, Nathalie Chaput, Cédric Ménard, et al.
Plos One|November 20, 2020
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19Thierry Poynard, Olivier Deckmyn, Marika Rudler, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2018
LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosisThierry Poynard, Valentina Peta, Olivier Deckmyn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injuryMaria Mikus, Kimi Drobin, Marcus Gry, et al.
Hepatology (Baltimore, Md.)|December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesPierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
Pageof 23

Showing results (201-210 of 222) with videos related to

Sort By:
Pageof 23
Diabetes Care|April 12, 2023
High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low ThresholdLaurent Castera, Cédric Laouenan, Anaïs Vallet-Pichard, et al.
Journal of Clinical Medicine|December 8, 2019
Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV InfectionChristiana Graf, Antonia Mondorf, Viola Knop, et al.
Gastroenterology|May 26, 2012
Factors that predict response of patients with hepatitis C virus infection to boceprevirFred Poordad, Jean-Pierre Bronowicki, Stuart C Gordon, et al.
Journal of Hepatology|June 11, 2023
Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosisLaure Elkrief, Nathalie Ganne-Carrié, Hana Manceau, et al.
Plos One|December 30, 2017
Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recoveryValentina Peta, Chantal Tse, Hugo Perazzo, et al.
Nature Medicine|January 31, 2006
A novel dendritic cell subset involved in tumor immunosurveillanceJulien Taieb, Nathalie Chaput, Cédric Ménard, et al.
Plos One|November 20, 2020
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19Thierry Poynard, Olivier Deckmyn, Marika Rudler, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2018
LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosisThierry Poynard, Valentina Peta, Olivier Deckmyn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2016
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injuryMaria Mikus, Kimi Drobin, Marcus Gry, et al.
Hepatology (Baltimore, Md.)|December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesPierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
Pageof 23